OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection.
OxCan has raised $11.0M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
OxCan's investors include Civilization Ventures, Eka Ventures, DigitalDx Ventures, MegaRobo, Cross-Border Impact Ventures.
OxCan is headquartered in Oxford, United Kingdom.
OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection.
OxCan is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OxCan — Funding & Investors." VCBacked, January 9, 2025, https://www.vcbacked.co/company/oxcan. Accessed September 15, 2026.
VCBacked. (2025). OxCan — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/oxcan
{{cite web |title=OxCan — Funding & Investors |url=https://www.vcbacked.co/company/oxcan |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated